194 related articles for article (PubMed ID: 21544866)
21. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism.
Firek AF; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510
[TBL] [Abstract][Full Text] [Related]
22. Infusions of parathyroid hormone in ruminants: hypercalcemia and reduced plasma 1,25-dihydroxyvitamin D concentrations.
Hove K; Horst RL; Littledike ET; Beitz DC
Endocrinology; 1984 Mar; 114(3):897-903. PubMed ID: 6546544
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone.
Kirby BJ; Ma Y; Martin HM; Buckle Favaro KL; Karaplis AC; Kovacs CS
J Bone Miner Res; 2013 Sep; 28(9):1987-2000. PubMed ID: 23505097
[TBL] [Abstract][Full Text] [Related]
24. In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH.
Ueno Y; Shinki T; Nagai Y; Murayama H; Fujii K; Suda T
J Cell Biochem; 2003 Oct; 90(2):267-77. PubMed ID: 14505343
[TBL] [Abstract][Full Text] [Related]
25. PTH-related protein is released into the mother's bloodstream during lactation: evidence for beneficial effects on maternal calcium-phosphate metabolism.
Lippuner K; Zehnder HJ; Casez JP; Takkinen R; Jaeger P
J Bone Miner Res; 1996 Oct; 11(10):1394-9. PubMed ID: 8889837
[TBL] [Abstract][Full Text] [Related]
26. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of various lengths of synthetic human parathyroid hormone-related peptide (hPTHrP) of malignancy on bone resorption and formation in organ culture.
Pilbeam CC; Alander CB; Simmons HA; Raisz LG
Bone; 1993; 14(5):717-20. PubMed ID: 8268045
[TBL] [Abstract][Full Text] [Related]
28. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
29. Exogenous PTH and endogenous 1,25-dihydroxyvitamin D are complementary in inducing an anabolic effect on bone.
Samadfam R; Xia Q; Miao D; Hendy GN; Goltzman D
J Bone Miner Res; 2008 Aug; 23(8):1257-66. PubMed ID: 18348699
[TBL] [Abstract][Full Text] [Related]
30. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
Endo K; Katsumata K; Hirata M; Masaki T; Kubodera N; Nakamura T; Ikeda K; Ogata E
J Bone Miner Res; 2000 Jan; 15(1):175-81. PubMed ID: 10646127
[TBL] [Abstract][Full Text] [Related]
31. A computational study of the dual effect of intermittent and continuous administration of parathyroid hormone on bone remodeling.
Zhao Y; Zhang G
Acta Biomater; 2019 Jul; 93():200-209. PubMed ID: 30954625
[TBL] [Abstract][Full Text] [Related]
32. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
33. The calcium-sensing receptor mediates bone turnover induced by dietary calcium and parathyroid hormone in neonates.
Shu L; Ji J; Zhu Q; Cao G; Karaplis A; Pollak MR; Brown E; Goltzman D; Miao D
J Bone Miner Res; 2011 May; 26(5):1057-71. PubMed ID: 21542007
[TBL] [Abstract][Full Text] [Related]
34. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
Lewin E; Garfia B; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396
[TBL] [Abstract][Full Text] [Related]
35. Resistance to bone resorbing effects of PTH in black women.
Cosman F; Morgan DC; Nieves JW; Shen V; Luckey MM; Dempster DW; Lindsay R; Parisien M
J Bone Miner Res; 1997 Jun; 12(6):958-66. PubMed ID: 9169356
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans.
Fraher LJ; Klein K; Marier R; Freeman D; Hendy GN; Goltzman D; Hodsman AB
J Clin Endocrinol Metab; 1995 Jan; 80(1):60-4. PubMed ID: 7829640
[TBL] [Abstract][Full Text] [Related]
37. Effect of parathyroid hormone on renal calbindin-D28k.
Hemmingsen C; Staun M; Lewin E; Nielsen PK; Olgaard K
J Bone Miner Res; 1996 Aug; 11(8):1086-93. PubMed ID: 8854244
[TBL] [Abstract][Full Text] [Related]
38. 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
Monier-Faugere MC; Geng Z; Friedler RM; Qi Q; Kubodera N; Slatopolsky E; Malluche HH
Kidney Int; 1999 Mar; 55(3):821-32. PubMed ID: 10027919
[TBL] [Abstract][Full Text] [Related]
39. The abnormal phenotypes of cartilage and bone in calcium-sensing receptor deficient mice are dependent on the actions of calcium, phosphorus, and PTH.
Liu J; Lv F; Sun W; Tao C; Ding G; Karaplis A; Brown E; Goltzman D; Miao D
PLoS Genet; 2011 Sep; 7(9):e1002294. PubMed ID: 21966280
[TBL] [Abstract][Full Text] [Related]
40. Parathyroid hormone temporal effects on bone formation and resorption.
Kroll MH
Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
